Molecular Transport Medium Market

Molecular Transport Medium Market Outlook (2024 to 2034)

The global molecular transport medium market value was US$ 234.6 million in 2019. The market is estimated to be around US$ 785.2 million in 2024. The molecular transport medium industry is predicted to expand at a CAGR of 4.5% from 2024 to 2034. The valuation of the market is forecasted to reach US$ 1,214 million by 2034.

The need for molecular sample transport medium is increasing noticeably with the growing usage of molecular diagnostics, such as polymerase chain reaction (PCR) and nucleic acid testing. The increasing requirement for dependable sample preservation in diagnostic procedures is propelling the demand for molecular transport mediums. The rise of biobanking operations are also expected to fuel growth in the market.

In the pandemic years of 2020 and 2021, the demand for collection and transport mediums boomed with the heightened requirement for COVID-19 tests. Following 2019, the market players witnessed a continued demand for molecular transport medium due to increased investment in research and development in biotechnology.

Molecular Transport Medium Market Trends and Analysis

Molecular transport media has evolved rapidly in the last few years as a result of constant improvements in technology and tools related to molecular biology. So, to guarantee sample integrity and stability for a range of molecular investigations, market players are investing heavily in the development and adoption of universal transport mediums.

The necessity for dependable sample transport options came into light with the growing use of point-of-care testing procedures during the pandemic years. This trend shifted the focus of molecular transport medium suppliers to assist in the decentralization of diagnostic services by providing goods that work in localized testing environments.

Report Attributes	Details
Estimated Market Value (2024E)	US$ 785.2 million
Forecasted Market Value (2034F)	US$ 1,214 million
Global Market Growth Rate (2024 to 2034)	4.5% CAGR
Active Transport Medium Segment Growth Rate (2024 to 2034)	5.3% CAGR
Mycobacterial and Fungal Infection Segment Growth Rate (2024 to 2034)	5.2% CAGR
Nasal Washes and Swab Segment Growth Rate (2024 to 2034)	5.1% CAGR
North America Market Share (2024)	4.8%
East Asia Market Share (2024)	5.3%
Key Companies Profiled	Thermo Fisher Scientific Inc. Becton, Dickinson, and Company Cardinal Health Quidel Corporation Medical Wire & Equipment COPAN Diagnostics Inc. Titan Biotech Ltd. Alpha Teknova, Inc. [former named Teknova] Bio-Genex Laboratories Inc. EKF Diagnostics Trinity Biotech Alpha-Tec Systems, Inc. Charm Sciences, Inc. Azer Scientific bioBoaVista AccuGene KSL Diagnostics Puritan Medical Products Amazing Biotech (Shanghai) Co., Ltd.

What are the Current Trends Driving the Molecular Transport Medium Market?

“Significant Rise in Biobanking Operations and Strengthening of International Standards”

There is a growing demand for genetic material transport solutions due to the rise of biobanking operations with higher investments by government organizations for the establishment of biotechnology research institutes. So, leading suppliers of molecular transport media are proactively positioning themselves in strategic locations to support biobanks that need standardized and safe sample preservation solutions within a short time period.

The formulation of international standards for transferring biological samples across borders has motivated molecular transport medium manufacturers to produce globally compatible, standardized solutions. In addition to this, the advent of precision medicine techniques has also increased the demand for nucleic acid preservation and transport mediums in recent years.

Country-wise Insights

Country	CAGR (2024 to 2034)
United States	4.9%
China	5.7%

Why is China Increasing its Production Capacity of Molecular Transport Mediums?

“Growing Applications of Preservation Transport Medium in China’s Molecular Pathology Industry”

The molecular transport medium industry in East Asia is estimated to be valued at US$ 125 million in 2024. The market in East Asia is expanding rapidly as a result of the growth of molecular pathology services, which include molecular testing for the diagnosis of cancer and viral diseases. The overall demand for molecular transport mediums in China, Japan, and South Korea is expected to follow an average CAGR of 5.3% from 2024 to 2034.

China is the leading country in East Asia for the production of molecular transport mediums and it is estimated to hold almost 47.4% of the regional market share in 2024. The development of integrated solutions facilitated by partnerships between suppliers of molecular transport medium and diverse industries, such as healthcare, research, and logistics, is driving the market in China.

Sales of molecular transport mediums in China are expected to surge at a CAGR of 5.7% through 2034. Japan follows China closely in the production and utilization of preservation transport mediums, with an estimated market value of US$ 50 million in 2024. The market in Japan is expected to progress at a CAGR of 5.2% to reach a valuation of US$ 83 million by 2034.

What is Fueling Demand for Molecular Transport Mediums in the United States?

“Presence of Advanced Biotechnology Research Facilities in the United States”

The total demand for molecular transport mediums in the United States, Canada, and Mexico combined is estimated to be valued at US$ 323 million in 2024. Due to liberal market regulations, molecular collection, and the presence of numerous transport medium market players, North American countries work in tandem with biotech and pharmaceutical businesses. These countries guarantee the integrity of biological samples used in medication development, driving market growth.

With a highly developed network of microbiological research institutes, the United States is the leading consumer of molecular transport mediums in North America. The net revenue generated from sales of biological sample preservation and transport medium in the country is estimated to be around US$ 295 million in 2024. Adequate RNA extraction and transportation mediums are in greater demand in the United States due to their essentiality in molecular analysis by the extensive network of biopharmaceutical research institutes.

The United States market is expected to progress at a CAGR of 4.9% through 2034. The markets in Canada and Mexico are expected to progress at CAGRs of 3.4% and 2.4%, respectively, during the forecast period.

Category-wise Insights

Which Type of Molecular Transport Mediums are Highly Preferred by End Users?

“Inactivated Transport Mediums are Gaining Higher Traction in Market”

Attribute	Details
Market Share in 2024	60.7%

In 2024, the net revenue generated from sales of inactivated transport medium is estimated to be around US$ 476.6 million, which is almost 60.7% of the total revenue. Through the forecasted period, the demand for inactivated or dry transport mediums is anticipated to advance at an annual growth rate of 3.9%. As service providers require efficient coordination of efforts to facilitate the transfer of biological samples that are essential for genetic research, inactivated transport mediums are in greater demand these days.

The active transport medium segment is expected to witness a higher growth rate of 5.3% during the projected years.

Competitive Landscape in the Molecular Transport Medium Market

A few leading market players capture a sizable share of the total market as they offer validated and standardized transport media to assure quality control and uniformity in molecular diagnostics. Meanwhile, new players entering the market are focusing on adapting their offerings to meet the changing requirements of pathology labs and other small-scale pharmaceutical industries.

Thermo Fisher Scientific Inc., Becton, Dickinson, and Company, Cardinal Health, etc. are some of the key players in the market.

Recent Developments in the Molecular Transport Medium Market

• In February 2021, Alpha Teknova Incorporation built new clean rooms that complied with ISO 13485 and GMP regulations, as it is crucial for the production of saline, active viral transport mediums (ATMs), and viral transport mediums (VTMs). Additionally, Teknova increased the manufacturing capacity for its line of viral transport mediums, which includes the VTM and ATM, due to the rising demand for biological sample transport mediums.
• In June 2020, bioBoaVista Company introduced a viral transport medium (MTV) in the market in response to the growing requirement for convenient nasal tests for the detection of COVID-19 and other viral diseases. The institution also claims that it is prepared from a special composition that prevents other pathogens from contaminating the sample and prevents it from being unstable.

Key Segments Covered by Molecular Transport Medium Industry Survey Report

• By Product Type:

  • Active Transport Medium
  • Inactivated Transport Medium

• By Application:

  • Virus
    • COVID-19
    • Middle East Respiratory Syndrome (MERS)
    • Influenza
    • Human Immunodeficiency Virus (HIV)
    • Rhinovirus
    • Adenovirus
    • Respiratory Syncytial Virus (RSV)
  • Bacteria
    • Staphylococcus Pneumonia
    • Haemophilus Influenza
    • Anthrax
    • Other Bacteria
  • Atypical Bacteria
    • Mycoplasma
    • Q-Fever
    • Other Atypical Bacteria
  • Mycobacterial and Fungal Infection

• By Sample:

  • Nasal Washes and Swabs
  • Sputum
  • Saliva
  • Faecal & Stool
  • Urine
  • Blood
  • Tissues
  • Other Samples

• By End-user Verticals:

  • Diagnostic Laboratories
  • Microbiology Laboratories
  • Hospitals & Clinics
  • Other End User Verticals

• By Region:

  • North America Market
  • Europe Market
  • Latin America Market
  • East Asia Market
  • South Asia & Oceania Market
  • Middle East & Africa (MEA) Market